Patents by Inventor Edgard Brauner

Edgard Brauner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for prevention and/or treatment of thrombocytopenia
    Patent number: 6183756
    Abstract: The present invention is directed to a method of treating subjects exhibiting thrombocytopenia or at risk of developing thrombocytopenia. The method includes the step of administering to the subject exhibiting thrombocytopenia or at risk of developing thrombocytopenia, an effective amount of a Pseudomonas solvent extract or active fraction thereof. The Pseudomonas solvent extract is administered in an amount effective to increase platelet levels in the subject.
    Type: Grant
    Filed: May 1, 1997
    Date of Patent: February 6, 2001
    Assignee: Dynagen, Inc.
    Inventors: Nicolae Istrate, Gita Muni, Edgard Brauner, Fazal Raheman
  • Methods for treatment of human immunodeficiency virus infection with pseudomonas phosphoaminolipid extract
    Patent number: 5853738
    Abstract: The present invention is directed to a method of treating individuals infected with HIV or at risk of being infected with HIV. The method comprises the step of administering to an individual infected with HIV or at risk of being infected with HIV, an effective amount of a phosphoaminolipid extract derived from bacteria. The phosphoaminolipid extract exhibits an immunomodulating effect in humans, promoting a stabilization or improvement in immune system function.
    Type: Grant
    Filed: October 30, 1995
    Date of Patent: December 29, 1998
    Assignee: Dynagen, Inc.
    Inventors: Nicolae Istrate, Gita Muni, Edgard Brauner, Fazal Raheman
  • Methods for prevention and/or treatment of neutropenia
    Patent number: 5851534
    Abstract: The present invention is directed to a method of treating individuals exhibiting neutropenia or at risk of neutropenia. The method comprises the step of administering to an individual exhibiting neutropenia or at risk of neutropenia, an effective amount of a colony modulating factor derived from bacteria. The colony factor modulator exhibits an immunomodulating effect in humans and promotes a stabilization or increase in neutrophil count.
    Type: Grant
    Filed: May 3, 1996
    Date of Patent: December 22, 1998
    Assignee: Dynagen, Inc.
    Inventors: Fazal Raheman, Nicolae Istrate, Gita Muni, Edgard Brauner